BERKELEY HEIGHTS, N.J., Oct. 1, 2021 /PRNewswire/ -- Vertice Pharma announces the results of a recent study demonstrating the bioequivalence of Thyquidity™, an oral liquid solution of levothyroxine sodium to Synthroid®. The study results were presented on September 30, 2021 during a virtual poster session at the 90th annual meeting of the American Thyroid Association.